Home Cart Sign in  
Chemical Structure| 33286-22-5 Chemical Structure| 33286-22-5

Structure of (+)-cis-Diltiazem HCl
CAS No.: 33286-22-5

Chemical Structure| 33286-22-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Diltiazem HCl is a benzothiazepine derivative with vasodilating action due to its antagonism of the actions of the calcium ion in membrane functions.

Synonyms: CRD-401; Diltiazem (hydrochloride); (+)-cis-Diltiazem

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of (+)-cis-Diltiazem HCl

CAS No. :33286-22-5
Formula : C22H27ClN2O4S
M.W : 450.98
SMILES Code : CC(O[C@H]1C(N(CCN(C)C)C2=CC=CC=C2S[C@H]1C3=CC=C(OC)C=C3)=O)=O.[H]Cl
Synonyms :
CRD-401; Diltiazem (hydrochloride); (+)-cis-Diltiazem
MDL No. :MFCD00069252
InChI Key :HDRXZJPWHTXQRI-BHDTVMLSSA-N
Pubchem ID :62920

Safety of (+)-cis-Diltiazem HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302+H312+H332-H319-H351-H361
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • Calcium Channel

In Vitro:

Cell Line
Concentration Treated Time Description References
MDA-MB-231 cells 1-100 μM 10 days Diltiazem significantly reduced colony formation in MDA-MB-231 cells, with 100 μM treatment reducing colony formation to 0.22±0.05-fold of control. PMC9376069
4T1 cells 1-100 μM 10 days Diltiazem significantly reduced colony formation in 4T1 cells, with 100 μM treatment reducing colony formation to 0.33±0.08-fold of control. PMC9376069
JC cells 1-100 μM 10 days Diltiazem significantly reduced colony formation in JC cells, with 100 μM treatment reducing colony formation to 0.23±0.05-fold of control. PMC9376069
Cardiomyocytes 1 μM 5 min To evaluate the effect of Diltiazem on contractile function and calcium transients in cardiomyocytes. Results showed that Diltiazem improved diastolic function and reduced arrhythmia incidence in KI cardiomyocytes under stress conditions. PMC5471503
Cardiac myocytes 10 μM To evaluate the effect of Diltiazem on mitochondrial membrane potential, results showed that Diltiazem attenuated the BayK(-)-induced increase in mitochondrial membrane potential PMC6113168

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c mice 4T1-luc breast cancer lung metastasis model Oral gavage 1-3 mg/kg Once daily, 5 days a week for 30 days Diltiazem significantly reduced lung metastasis and nodule formation of 4T1-luc cells and increased GDF-15 expression. PMC9376069
New Zealand white rabbits Hypertensive model Transdermal administration 30 mg 24 hours To evaluate the antihypertensive effect of Diltiazem HCl transdermal patch, results showed sustained reduction in arterial blood pressure PMC4856784
Male Albino Swiss mice Mybpc3-targeted knock-in mouse model Drinking water 25 mg/kg Once daily for 6 months To evaluate the effect of long-term Diltiazem treatment on the cardiac phenotype of KI mice. Results showed that long-term Diltiazem treatment did not reverse cardiac hypertrophy, dysfunction, activation of the fetal gene program, or fibrosis. PMC5471503
Mice Transgenic mouse models of cTnT R92L and R92W Drinking water 1.8 mg Continued for three months, with treatment water changed every two days. To evaluate the effects of Diltiazem-HCl on improving diastolic function. Results showed that Diltiazem-HCl treatment arrested diastolic dysfunction progression in R92W animals only, with no improvement in cardiac remodeling in either genotype. PMC6461395
Mice Primary hyperparathyroidism model Oral 100mg/kg Daily administration for 2 weeks Diltiazem prevents cPTH-induced bone loss by inhibiting Th17 cell expansion and bone resorption. PMC4635034

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02203630 Septic Shock ... More >>Sepsis Shock Tachycardia Arrhythmia Less << Phase 4 Terminated(Slow enrollment; La... More >>ck of support and equipoise) Less << - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT02203630 - Terminated(Slow enrollment; La... More >>ck of support and equipoise) Less << - -
NCT00000620 Atherosclerosis ... More >> Cardiovascular Diseases Hypercholesterolemia Hypertension Diabetes Mellitus, Type 2 Diabetes Mellitus Coronary Disease Less << Phase 3 Completed - United States, Minnesota ... More >> Minneapolis Medical Research Foundation Minneapolis, Minnesota, United States, 55404 United States, New York Columbia University New York, New York, United States, 10027 United States, North Carolina Wake Forest University Winston-Salem, North Carolina, United States, 27106 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Tennessee Veterans Affairs Memphis, Tennessee, United States, 38104 United States, Washington University of Washington Seattle, Washington, United States, 98195 Canada, Ontario McMaster University Hamilton, Ontario, Canada Less <<
NCT00000620 - Completed - -
NCT01688648 Unstable Angina ... More >> Coronary Artery Bypass Graft Dexmedetomidine Lidocaine Myocardial Injury Arrhythmia Blood Electrolyte Balance Less << Not Applicable Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT00803634 Hypertension ... More >>Heart Failure Less << Phase 3 Completed - United States, Alabama ... More >> Jackson Hospital Montgomery, Alabama, United States, 36106 United States, California Centinela Hospital Inglewood, California, United States, 90301 United States, Louisiana Louisiana State University Health Sciences Center Baton Rouge, Louisiana, United States, 70805 Louisiana State University Health Sciences Center - Emergency Medicine New Orleans, Louisiana, United States, 70112 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110 United States, New York Stony Brook University and Medical Center Stony Brook, New York, United States, 11794 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio University of Cincinnati Cincinnati, Ohio, United States, 45267 The Cleveland Clinic Cleveland, Ohio, United States, 44195 France Hopial AP-HP Hotel-Dieu Paris, France, 75004 Hopital AP-HP La Pitie Sapetriere Paris, France, 75013 Hopital AP-HP Lariboisiere Urgencies-SMUR Paris, France, 75475 Germany Charité - Universitätsmedizin Berlin Berlin, Germany, 13353 Less <<
NCT00283686 Kidney, Polycystic Phase 3 Completed - United States, Colorado ... More >> University of Colorado Health Sciences Center Denver (Aurora), Colorado, United States, 800045 United States, Georgia Emory University School of Medicine Atlanta, Georgia, United States, 30322 United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States, 66160 United States, Massachusetts Tufts University-New England Medical Center Boston, Massachusetts, United States, 02111 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Less <<
NCT00803634 - Completed - -
NCT00413712 Supraventricular Tachycardia Phase 4 Completed - Singapore ... More >> Singapore General Hospital Singapore, Singapore, 62223322 Less <<
NCT00000556 Arrhythmia At... More >>rial Fibrillation Cardiovascular Diseases Heart Diseases Less << Phase 3 Completed - -
NCT00582777 Hypertensive Renal Disease Phase 2 Phase 3 Completed - United States, Alabama ... More >> University of Alabama Birmingham, Alabama, United States, 35233 United States, California University of Southern California Los Angeles, California, United States, 90033 Charles Drew Medical College Los Angeles, California, United States, 90059 University of California at San Diego San Diego, California, United States, 92161 United States, Florida University of Florida Gainesville, Florida, United States, 32611 University of Miami Miami, Florida, United States, 33101 United States, Georgia Emory University Atlanta, Georgia, United States, 30308 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21205 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48106 United States, New York Lenox Hill Hospital New York, New York, United States, 10021 United States, Ohio University Hospitals of Cleveland Cleveland, Ohio, United States, 44106 Ohio State University Columbus, Ohio, United States, 43210 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37232 United States, Texas Univesity of Texas Southwestern Medical Center at Dallas Dallas, Texas, United States, 75390 Less <<
NCT00578617 Atrial Fibrillation ... More >> Arrhythmia Less << Not Applicable Completed - United States, Alabama ... More >> Universtity of Alabama Hospital Birminham, Alabama, United States, 35233 United States, California Good Samaritan Hospital Los Angeles, California, United States, 90017 United States, Illinois Loyola University Maywood, Illinois, United States, 60626 United States, Iowa Mercy Medical Center Des Moines, Iowa, United States, 50314 United States, Maryland Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 United States, Massachusetts Brigham and Womens Hospital Boston, Massachusetts, United States, 02115 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55902 United States, Ohio Ohio State University Medical Center Columbus, Ohio, United States, 43210 United States, Pennsylvania University of Pennsylvania Health Philadelphia, Pennsylvania, United States, 19104 United States, Utah Intermountain Medical Center Murray, Utah, United States, 84157 Less <<
NCT01279499 Morbid Obesity Phase 2 Phase 3 Unknown July 2011 Greece ... More >> University Hospital of Patras, Departement of Anesthesiology and Critical Care Medicine Recruiting Patras, Achaia, Greece, 26500 Contact: Kriton Filos, Professor    00302610999341    kritonfilos@yahoo.gr Less <<
NCT00552669 Coronary Heart Disease ... More >> Coronary Restenosis Less << Phase 4 Completed - Argentina ... More >> Clinica IMA Adrogue, Buenos Aires, Argentina, 1846 Sanatorio Las Lomas San Isidro, Buenos Aires, Argentina, 1354 Sanatorio Otamendi y Miroli Buenos Aires, Argentina, 1115 Less <<
NCT00552669 - Completed - -
NCT00283686 - Completed - -
NCT00911508 Atrial Fibrillation ... More >> Arrhythmia Less << Not Applicable Completed - -
NCT00000478 Cardiovascular Diseases ... More >> Coronary Disease Heart Diseases Myocardial Ischemia Less << Phase 3 Completed - -
NCT00578617 - Completed - -
NCT02364089 Adrenal Incidentalomas Not Applicable Recruiting December 2021 France ... More >> Service de Médecine Interne, Endocrinologie et Nutrition - CHU de Strasbourg Recruiting Strasbourg, Alsace, France, 67000 Contact: Bernard GOICHOT, Professor    +33 3 88 12 75 93    Bernard.Goichot@chru-strasbourg.fr    Service Endocrinologie, Diabétologie, maladies métaboliques - CHU de Bordeaux Recruiting Pessac, Aquitaine, France, 33600 Contact: Antoine TABARIN, Professor    +33 5 57 65 64 33    antoine.tabarin@chu-bordeaux.fr    Contact: Sarah CAZENAVE    +33 5 57 65 62 77    sarah.cazenave@chu-bordeaux.fr    Service d'Endocrinologie - Niveau 18 - Caen CHU Côte de Nacre Recruiting Caen, Basse-Normandie, France, 14000 Contact: Yves REZNIK, Professor    +33 2 31 06 45 86    reznik-y@chu-caen.fr    Service d'Endocrinologie -Diabète-Nutrition - CHU de REIMS Not yet recruiting Reims, Champagne-Ardenne, France, 51000 Contact: Brigitte DELEMER, Doctor    +33 3 26 78 81 01    bdelemer@chu-reims.fr    Service d'Endocrinologie, Diabétologie, Nutrition - CHU d'Amiens Not yet recruiting Amiens, Haut De France, France, 80000 Contact: Rachel DESAILLOUD, Pr    03.22.45.58.97 ext +33    Desailloud.Rachel@chu-amiens.fr    Endocrinologie, Diabète et Maladies Métaboliques - CHU de Rouen Not yet recruiting Rouen, Haute-Normandie, France, 76000 Contact: Hervé LEFEBVRE, Professor    +33 2 32 88 90 81    Herve.Lefebvre@chu-rouen.fr    Service d'Endocrinologie et des Maladies de la Reproduction- Assistance Publique - Hôpitaux de Paris - Hôpial Bicêtre Recruiting Le Kremlin Bicêtre, ILE DE France, France, 94275 Contact: Jacques YOUNG       jacques.young@bct.ap-hop-paris.fr    Assistance Publique - Hôpitaux de Paris - Hôpital COCHIN Recruiting Paris, ILE DE France, France, 75014 Contact: Jérôme BERTHERAT, Professor    +33 1 58 41 18 95    jerome.bertherat@ch.aphp.fr    Service d'Endocrinologie et Gynécologie - Assistance Publique - Hôpitaux de Paris - Pitié-Salpêtrière Withdrawn Paris, ILE DE France, France, 75651 Service d'Hypertension et de Médecine Vasculaire - Assistance Publique - Hôpitaux de Paris - Hôpital européen Georges Pompidou Recruiting Paris, ILE DE France, France, 75908 Contact: Pierre-François PLOUIN, Professor    +33 1 56 09 37 71    pierre-francois.plouin@egp.aphp.fr    Service d'Endocrinologie - Saint-Antoine - AP-HP Not yet recruiting Paris, Ile De France, France Contact: Sophie CHRISTIN-MAITRE, Pr    01.49.28.24.10 ext +33    sophie.christin-maitre@aphp.fr    Service d'Endocrinologie - CHU de Nancy Withdrawn Nancy, Lorraine, France, 54000 Service d'Endocrinologie et Maladies Métabolique - CHU de Toulouse Recruiting Toulouse, Midi-Pyrénées, France, 31000 Contact: Philippe CARON, Professor    +33 5 67 77 17 01    caron.p@chu-toulouse.fr    Service d'Endocrinologie, Diabétologie et Métabolisme - CHRU de LILLE Recruiting Lille, Nord-Pas-de-Calais, France, 59000 Contact: Marie-Christine VANTYGHEM, Professor    +33 3 20 44 45 35    mc-vantyghem@chru-lille.fr    Département Endocrinologie-Diabétologie -Nutrition - CHU d'ANGERS Recruiting Angers, Pays De La Loire, France, 49000 Contact: Sandrine LABOUREAU-SOARES, Doctor    +33 2 41 35 45 93    sasoares@chu-angers.fr    CIC Endocrinologie-Nutrition - CHU de Nantes Recruiting Nantes, Pays De La Loire, France, 44000 Contact: Bertrand CARIOU, Professor    +33 2 53 48 27 07    bertrand.cariou@univ-nantes.fr    Service d'Endocrinologie, Diabète et Maladies Métaboliques - Assistance publique - Hôpitaux de Marseille Recruiting Marseille, Provence-Alpes-Côte d'Azur, France, 13000 Contact: Thierry BRUE, Professor    +33 4 91 38 65 97    Thierry.BRUE@ap-hm.fr    Service Endocrinologie - CHU de Saint-Etienne Withdrawn Saint-Etienne, Rhône-Alpes, France, 42000 CHU de Poiriers Not yet recruiting Poitiers, France, 86021 Contact: Mathilde FRATY, Dr       mathilde.fraty@chu-poitiers.fr    Germany Endokrinologie, Diabetes und Ernährungsmedizin, Campus Mitte, Medizinische Klinik - Charité - Universitätsmedizin Berlin Not yet recruiting Berlin, Germany, 10117 Contact: Tina Kienitz       tina.kienitz@charite.de    Medizinische Klinik und Poliklinik IV, Endocrine Research Unit - Ludwig-Maximilians-Universität Not yet recruiting München, Germany, 80336 Contact: Felix Beuschlein       Felix.Beuschlein@med.uni-muenchen.de    Department of Internal Medicine I, Endocrine and Diabetes Uni -University Hospital Würzburg Recruiting Würzburg, Germany, 97080 Contact: Martin FAßNACHT, Pr       Fassnacht_M@ukw.de    Italy Clinica di Endocrinologia e Malattie del Metabolismo, Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona Not yet recruiting Ancona, Italy Contact: Giorgio Arnaldi       Giorgio.Arnaldi@ospedaliriuniti.marche.it    S Orsola-Malpighi Hospital Recruiting Bologna, Italy, 40138 Contact: Uberto Pagotto       uberto.pagotto@unibo.it    University-Hospital of Padova Not yet recruiting Padova, Italy, 35128 Contact: Carla Scaroni       carla.scaroni@unipd.it    "Casa Sollievo della Sofferenza" Hospital Not yet recruiting San Giovanni Rotondo, Italy, 71013 Contact: Alfredo Scillitani       endocrino@operapadrepio.it    Dipartimento di Scienze Cliniche e Biologiche, Università degli Studi di Torino Not yet recruiting Torino, Italy, 10043 Contact: Massimo Terzolo       massimo.terzolo@unito.it Less <<
NCT01334203 Angina Pectoris ... More >> Coronary Artery Disease Type 2 Diabetes Mellitus Less << Phase 4 Withdrawn December 2012 -
NCT01176565 Intracerebral Hemorrhage Phase 3 Terminated(Planned interim ana... More >>lysis no significant outcome differences between groups) Less << - -
NCT00863213 Atrial Fibrillation Phase 4 Completed - Spain ... More >> Hospital de Cruces Bilbao, Bizkaia, Spain Hospital Clinic Universitari Barcelona, Spain, 08036 Hospital de Sant Pau Barcelona, Spain Clínica Puerta de Hierro Madrid, Spain Hospital 12 de Octubre Madrid, Spain Hospital Clínico San Carlos Madrid, Spain Hospital Gregorio Marañon Madrid, Spain Hospital Ramón y Cajal Madrid, Spain Less <<
NCT02020915 - Unknown July 2015 Denmark ... More >> Hvidovre University Hospital Recruiting Hvidovre, Denmark, DK-2650 Contact: Michael Sørensen, MD    +4538625457    michael.soerensen.02@regionh.dk    Principal Investigator: Michael Sørensen, MD Less <<
NCT00589303 Atrial Fibrillation ... More >> Heart Failure Less << Phase 3 Terminated(Lack of funding) - United States, Arizona ... More >> Mayo Clinic Arizona Scottsdale, Arizona, United States, 85259 United States, Indiana The Heart Group Evansville, Indiana, United States, 47710 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Tennessee Chattanooga Heart Institute Chattanooga, Tennessee, United States, 37404 Canada, Alberta University of Calgary and Calgary Health Region Calgary, Alberta, Canada, T2N-4N1 Less <<
NCT00589303 - Terminated(Lack of funding) - -
NCT01176565 - Terminated(Planned interim ana... More >>lysis no significant outcome differences between groups) Less << - -
NCT02265809 Type 1 Diabetes Phase 1 Phase 2 Completed - United Kingdom ... More >> Wellcome Trust Clinical Research Facility, Addenbrookes Hospital Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ Less <<
NCT02391337 Permanent Atrial Fibrillation Phase 4 Recruiting December 31, 2019 United Kingdom ... More >> City Hospital Recruiting Birmingham, West Midlands, United Kingdom Queen Elizabeth Hospital Recruiting Birmingham, West Midlands, United Kingdom Less <<
NCT00733239 Opioid Dependence Phase 1 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT00593463 Drug Dependence Phase 1 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT01505179 Heart Failure With Preserved E... More >>jection Fraction Less << Not Applicable Unknown - United States, California ... More >> University of California, San Diego San Diego, California, United States, 92037 Less <<
NCT02052011 Microvascular Angina Phase 4 Completed - United States, Connecticut ... More >> Yale New Haven Hospital New Haven, Connecticut, United States, 06510 Less <<
NCT02052011 - Completed - -
NCT01352416 - Terminated(lack of enrollment) - -
NCT00223717 Hypertension Phase 1 Completed - United States, Tennessee ... More >> Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT00039975 HIV Infections ... More >> Cardiovascular Diseases Hypertension Less << Phase 1 Completed - United States, California ... More >> Univ of California San Francisco San Francisco, California, United States, 94110 Stanford Univ Med Ctr Stanford, California, United States, 943055107 United States, Colorado Univ of Colorado Health Sciences Ctr Denver, Colorado, United States, 80262 United States, Maryland Johns Hopkins Hosp Baltimore, Maryland, United States, 21287 United States, Minnesota Univ of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Missouri Washington Univ (St. Louis) St. Louis, Missouri, United States, 63108 United States, New York Cornell Univ Med Ctr New York, New York, United States, 10021 Univ of Rochester Medical Center Rochester, New York, United States, 14642 United States, Ohio Univ of Cincinnati Cincinnati, Ohio, United States, 452670405 Less <<
NCT00684489 Hypertension Not Applicable Completed - -
NCT02503865 Metabolic Syndrome Phase 1 Phase 2 Completed - Kazakhstan ... More >> Republican Scientific Center for Emergency Medicine Astana, Kazakhstan, 010000 Less <<
NCT02300259 Healthy Volunteers Phase 1 Completed - United States, Florida ... More >> Covance Clinical Research Inc Daytona Beach, Florida, United States, 32117 Less <<
NCT03529149 Acute Ischemic Stroke Phase 4 Recruiting June 1, 2019 China, Beijing ... More >> Xuanwu Hospital Recruiting Beijing, Beijing, China, 100053 Contact: Su Yingying    15901361953    tangsuyingying@sina.com Less <<
NCT01352416 Heart; Dysfunction Postoperati... More >>ve, Cardiac Surgery Less << Phase 3 Terminated(lack of enrollment) - United States, Michigan ... More >> William Beaumont Hospital Royal Oak, Michigan, United States, 48073 William Beaumont Hospital Troy, Michigan, United States, 48085-1198 Less <<
NCT02503865 - Completed - -
NCT00164801 Non-Cardiac Chest Pain Not Applicable Terminated(Funding ended) - China ... More >> Endoscopy Centre, Prince of Wales Hospital Hong Kong, China Less <<
NCT03212716 Flu Phase 2 Recruiting August 2019 France ... More >> Hôpital Raymond Poincaré Recruiting Garches, France Principal Investigator: Djillali Annane, MD          Hôpital Roger Salengro, CHRU Recruiting Lille, France Principal Investigator: Julien Poissy, MD          Hôpital Edouard Herriot Hospices Civils de Lyon Recruiting Lyon, France Principal Investigator: Thomas Rimmelé, MD          CH de Montauban Recruiting Montauban, France Principal Investigator: Sylvie Vimeux, MD          Hôpital Bretonneau Recruiting Tours, France Principal Investigator: Denis Garot, MD Less <<
NCT00313157 Atrial Fibrillation Phase 3 Completed - Norway ... More >> Vestre Viken Hospital Trust, Baerum Hospital Rud, Akershus, Norway, 1309 Less <<
NCT01655303 Rapid Ventricular Response Atr... More >>ial Fibrillation Less << Phase 4 Completed - Iran, Islamic Republic of ... More >> Rasoul-e-Akram Hospital Tehran, Iran, Islamic Republic of, 14436151 Less <<
NCT03070470 Drug-induced QT Prolongation ... More >> Pharmacokinetics Pharmacodynamics Less << Phase 1 Completed - United States, Wisconsin ... More >> Spaulding Clinical Research West Bend, Wisconsin, United States, 53095 Less <<
NCT00712894 Acute Myocardial Infarction ... More >> Percutaneous Coronary Intervention Less << Phase 4 Completed - China, Shanghai ... More >> Zhongshan Hospital Fudan University Shanghai, Shanghai, China, 200032 Less <<
NCT00645463 Obesity Phase 1 Completed - United States, Michigan ... More >> Pfizer Investigational Site Ann Arbor, Michigan, United States, 48105 Less <<
NCT01162902 Stable Angina Phase 4 Unknown December 2015 Korea, Republic of ... More >> Seoul National University Hospital Not yet recruiting Seoul, Korea, Republic of Principal Investigator: Hyo-Soo Kim, MD, PhD          Sub-Investigator: Hae-Young Lee, MD,PhD Less <<
NCT00893100 Pain Phase 4 Completed - Iran, Islamic Republic of ... More >> Sina General Hospital Tehran, Iran, Islamic Republic of Less <<
NCT02922452 Ischemic Stroke Phase 1 Completed - United States, Texas ... More >> PPD Development Austin, Texas, United States, 78744 Less <<
NCT01124760 Pharmacokinetics Phase 1 Completed - United States, Kansas ... More >> Research Site Overland Park, Kansas, United States Less <<
NCT02695992 Atrial Fibrillation ... More >> Permanent Atrial Fibrillation Less << Phase 4 Recruiting December 2020 Norway ... More >> Vestre Viken Hospital Trust, Baerum Hospital Recruiting Rud, Akershus, Norway, 1309 Contact: Sara Reinvik Ulimoen, MD PhD    67809400 ext +47    sara.ulimoen@vestreviken.no    Principal Investigator: Sara Reinvik Ulimoen, MD PhD          Sub-Investigator: Arnljot Tveit, MD PhD          Sub-Investigator: Katrine Enge, MD Less <<
NCT01827735 Type 1 Diabetes Phase 1 Phase 2 Completed - United Kingdom ... More >> Wellcome Trust Clinical Research Facility, Addenbrooke's Hospital Cambridge, United Kingdom, CB2 0QQ Less <<
NCT02308748 Drug-induced QT Prolongation ... More >> Pharmacokinetics Pharmacodynamics Less << Phase 1 Completed - -
NCT02308748 - Completed - -
NCT02319148 Healthy Volunteers Phase 1 Completed - Belgium ... More >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 Less <<
NCT01021176 Food Intake Phase 1 Terminated - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT02419534 Fissure in Ano Phase 4 Unknown November 2016 Saudi Arabia ... More >> College of medicine, king saud university Recruiting Riyadh, Nejd Province - Central, Saudi Arabia Contact: Ayman Al-Jazaeri    (966)-5-65994455 Less <<
NCT02479204 Healthy Subjects Phase 1 Terminated(Based on results fr... More >>om the pilot phase, the study is terminated. No safety events leading to discontinuation were reported) Less << - France ... More >> BIOTRIAL Rennes, France, CS 34246 Less <<
NCT02653872 Healthy Subjects Phase 1 Completed - United Kingdom ... More >> Research Site London, United Kingdom Less <<
NCT02653872 - Completed - -
NCT01594619 Drug Induced Constipation Phase 1 Completed - United States, Kansas ... More >> Research Site Overland Park, Kansas, United States Less <<
NCT01408524 Hypertension ... More >>Craniotomy Less << Phase 1 Phase 2 Completed - -
NCT02319148 - Completed - -
NCT01211808 Atrial Fibrillation Phase 1 Completed - United States, Kansas ... More >> Pra International Lenexa, Kansas, United States, 66219 Less <<
NCT01151345 Healthy Phase 1 Completed - Mexico ... More >> Pfizer Investigational Site Mexico, DF, Mexico, 14050 Less <<
NCT02010970 Healthy Volunteers ... More >> Pharmacologic Action Less << Phase 1 Completed - United States, California ... More >> Research Site Cypress, California, United States Less <<
NCT02807909 Thrombosis Phase 1 Completed - -
NCT02158013 Chronic Anal Fissure Not Applicable Active, not recruiting February 5, 2018 Denmark ... More >> Department of Surgery P, Aarhus University Hospital Aarhus, Denmark, DK8000 Digestive Disease Center, Bispebjerg Hospital Copenhagen, Denmark, DK2400 Less <<
NCT00318201 Healthy Phase 4 Completed - United States, Indiana ... More >> Indiana University Medical Center / GCRC Indianapolis, Indiana, United States, 46202 Less <<
NCT01151345 - Completed - -
NCT00713011 Diabetic Nephropathies ... More >> Hypertension Less << Phase 3 Withdrawn(Study was stopped by... More >> sponsor prior to first patient assignment to groups due to operational reasons.) Less << March 2009 -
NCT02526888 Healthy Subjects Phase 1 Completed - Germany ... More >> CRS Clinical Research Services Kiel GmbH Kiel, Germany, 24105 Less <<
NCT00834925 Atrial Fibrillation Phase 4 Unknown August 2011 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of Contact: Sang Hoon Na, MD, PhD    +82-2-2072-3047    nasanghoon@gmail.com Less <<
NCT01771978 Ischaemia-reperfusion Injury Phase 3 Unknown - France ... More >> Department of Anaesthesiology Strasbourg, France, 67091 Less <<
NCT02938260 - Completed - -
NCT01422382 Healthy Phase 4 Completed - United States, Texas ... More >> Austin, Texas, United States Less <<
NCT01422382 - Completed - -
NCT02947711 Healthy Subjects Phase 1 Completed - United States, Texas ... More >> San Antonio, Texas, United States Less <<
NCT02024919 Coronary Artery Ectasia Not Applicable Completed - Turkey ... More >> Ankara University School Of Medicine, Department of Cardiology Ankara, Turkey, 06230 Less <<
NCT01645826 Idiopathic Pulmonary Arterial ... More >>Hypertension Primary Pulmonary Hypertension Pulmonary Arterial Hypertension Familial Primary Pulmonary Hypertension Less << Not Applicable Withdrawn(no participants agre... More >>ed to enroll since study start) Less << - United States, Florida ... More >> University of South Florida Tampa, Florida, United States, 33612 Less <<
NCT01914926 - Completed - -
NCT01852565 Atherosclerosis Phase 1 Completed - United States, Maryland ... More >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Less <<
NCT01914926 Heart Rate and Rhythm Disorder... More >>s Less << Phase 4 Completed - United States, New York ... More >> Maimonides Medical Center Brooklyn, New York, United States, 11219 Less <<
NCT02801305 Digital Ulcer of Scleroderma Phase 2 Completed - Iran, Islamic Republic of ... More >> Rheumatology Reseach Center, Shiraz University of Medical Sciences, Shiraz, Iran. Shiraz, Fars, Iran, Islamic Republic of Less <<
NCT01261156 Healthy Subjects Phase 1 Completed - Netherlands ... More >> PRA International Zuidlaren, Netherlands, 9471 Less <<
NCT03752931 Postoperative Cardiac Complica... More >>tion Less << Phase 2 Not yet recruiting December 2020 Tunisia ... More >> Hospital Abderrahmane Mami Recruiting Ariana, Tunisia Contact: Marzouk Mahmoud, MD    0021620874718    mahmoudmarzouk@hotmail.Fr Less <<
NCT01549496 Hepatitis C H... More >>ypertension Less << Phase 1 Withdrawn(Investigator left th... More >>is hospital) Less << - Canada, Ontario ... More >> Clinical Investigation Unit, Ottawa Hospital Research Institute Ottawa, Ontario, Canada, K1H8L6 Less <<
NCT00319982 Hypertrophic Cardiomyopathy Phase 2 Phase 3 Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Children's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT01816191 Adult Subjects With Anal Fissu... More >>res. Less << Phase 1 Unknown September 2013 United States, North Carolina ... More >> Wake Research Associates Raleigh, North Carolina, United States Less <<
NCT03580590 Hypotension on Induction Early Phase 1 Not yet recruiting January 1, 2020 -
NCT00319982 - Completed - -
NCT01690221 Chronic Anal Fissures Phase 3 Completed - -
NCT01821274 Skin Irritation Phase 1 Unknown September 2013 United States, New Jersey ... More >> TKL Research Paramus, New Jersey, United States, 07652 Less <<
NCT02025465 Atrial Fibrillation ... More >> Atrial Flutter Less << Phase 4 Recruiting December 2018 United States, West Virginia ... More >> Charleston Area Medical Center Recruiting Charleston, West Virginia, United States, 25304 Principal Investigator: William H. Carter, MD Less <<
NCT00983372 Healthy; Adult; Volunteer; Col... More >>chicine; Pharmacokinetics; Diltiazem; Cytochrome p450 3A4; P-glycoprotein Less << Phase 1 Completed - United States, North Dakota ... More >> PRACS Institute, Ltd. - Cetero Research Fargo, North Dakota, United States, 58104 Less <<
NCT01217515 Chronic Anal Fissure Phase 3 Completed - Bulgaria ... More >> Dr Kantcho Kostadinov Sevileva, Sevilieva, Bulgaria, 5400 Vth MHAT Sofia, Bulgaria, 1233 MHAT Alexandrovska EAD Sofia, Bulgaria, 1606 Military Medical Academy Sofia, Bulgaria, 1606 D Rusev Sofia, Bulgaria, 1618 General Hospital for Active Treatment "Stefan Cherkezov" Veliko Tarnovo, Bulgaria, 5000 Germany Praxis Blankenhain, Germany, 99444 Praxis Fürth, Germany, 90762 End- und Dickdarm-Zentrum Mannheim Mannheim, Germany, 68165 Gemeinschaftspraxis Marl, Germany, 45770 Practice of Internal Medicine Wiesbaden, Germany, 65185 Lithuania Kaunas Medical University Clinics Kaunas, Lithuania, 50009 Siauliai Hospital Siauliai, Lithuania, 76231 UAB Baltic and American Medical and Surgical Clinic Vilnius, Lithuania, 10103 Romania Spitalul Clinic de Urgenta "Prof Dr O Fodor" Cluj Cluj Nopoca, Romania, 400162 Spitalul Clinic de Urgenta "Prof. Dr O Fodor" Cluj-Napoca, Romania, 400162 Spitalul Judetean de Urgenta Deva Deva, Romania, 330084 Institutul de Gastroenterologie si Hepatologie lasi Lasi, Romania, 700111 Spitalul Clinic Judetean de Urgente "Sf.Spiridon" lasi Lasi, Romania, 700111 Cabinet Medical "Dr Lokos" Chirurgie Generala Miercurea Ciuc, Romania, 530180 Spitalul Clinic Judetean Mures Tg Mures, Romania, 540103 Centrul Medical Tuculanu SRL Timisoara, Romania, 300167 Spitalul Clinic Judetean de Urgenta Timisoara Timisoara, Romania, 300723 Salvo-San-Ciobanca SRL Zalau, Romania, 450112 Spain Hospital Clinico Universitario Lozano Blesa Zaragoza, Spain, 50009 United Kingdom Derby City General Hospital Derby, Derbyshire, United Kingdom, DE22 3DT Royal Sussex County Hospital Brighton, United Kingdom, BN2 5BE Less <<
NCT01217515 - Completed - -
NCT01816529 Diltiazem Skin Sensitivity. Phase 1 Unknown September 2013 United States, New Jersey ... More >> TKL Research Paramus, New Jersey, United States, 07652 Less <<
NCT02080780 - Completed - -
NCT00983372 - Completed - -
NCT03472495 Atrial Fibrillation and Flutte... More >>r Less << Phase 4 Recruiting March 2020 United States, Virginia ... More >> Virginia Commonwealth University Recruiting Richmond, Virginia, United States, 23298 Contact: Tammy T Nguyen, PharmD, BCPS    804-663-0969    tammy.nguyen@vcuhealth.org Less <<
NCT02080780 CLARITHROMYCIN/DILTIAZEM [VA D... More >>rug Interaction] Less << Phase 1 Completed - United States, New Jersey ... More >> TKL Research Paramus, New Jersey, United States, 07652 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.22mL

0.44mL

0.22mL

11.09mL

2.22mL

1.11mL

22.17mL

4.43mL

2.22mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories